0001415889-19-000021.txt : 20190107 0001415889-19-000021.hdr.sgml : 20190107 20190107184913 ACCESSION NUMBER: 0001415889-19-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181227 FILED AS OF DATE: 20190107 DATE AS OF CHANGE: 20190107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ross Edmund Burke Jr. CENTRAL INDEX KEY: 0001682557 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37853 FILM NUMBER: 19514318 MAIL ADDRESS: STREET 1: C/O JDJ FAMILY OFFICE SERVICES STREET 2: P.O. BOX 962049 CITY: BOSTON STATE: MA ZIP: 02196 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 BUSINESS PHONE: 646-699-7855 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 4 1 form4-01072019_030157.xml X0306 4 2018-12-27 0001604191 AzurRx BioPharma, Inc. AZRX 0001682557 Ross Edmund Burke Jr. C/O JDJ FAMILY OFFICE SERVICES PO BOX 962049 BOSTON MA 02196 false false true false Common Stock 2018-05-02 4 P 0 20000 2.50 A 2421010 I See Footnote Common Stock 2018-12-27 4 P 0 42922 1.18 A 2463932 I See Footnote Common Stock 2018-12-27 4 P 0 23200 1.13 A 2487132 I See Footnote Common Stock 2018-12-28 4 P 0 29575 1.18 A 2516707 I See Footnote Common Stock 2018-12-31 4 P 0 23848 1.12 A 2540555 I See Footnote Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest. Of the aggregate number of shares purchased on May 2, 2018, CEDA Investments, LLC purchased all 20,000 shares. Of the aggregate number of shares purchased on December 27, 2018, EBR Ventures, LLC purchased all 66,122 shares. Of the aggregate number of shares purchased on December 28, 2018, EBR Ventures, LLC purchased all 29,575 shares. Of the aggregate number of shares purchased on December 31, 2018, EBR Ventures, LLC purchased all 23,848 shares. /s/ Edmund Burke Ross Jr. for himself and as manager of ADEC Private Equity Investment, LLC, as manager of EBR Ventures, LLC, and as manager of CEDA Investments, LLC 2019-01-07